COMMUNIQUÉS West-GlobeNewswire

Achieve Life Sciences Announces Granting of New Hire Inducement Awards
02/10/2025
SEATTLE and VANCOUVER, British Columbia, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and [...]
Cidara Therapeutics Announces BARDA Award to Support Expanded Manufacturing and Clinical Development of CD388, its Non-Vaccine Influenza Preventative Therapeutic
02/10/2025
SAN DIEGO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) therapeutics, today announced [...]
Corvus Pharmaceuticals Appoints David Moore to Board of Directors
02/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, announced today that David Moore, Executive Vice President, US [...]
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/10/2025
BOSTON, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous [...]
Algae-C Inc. Announces Completion of Acquisition by Rockcliffe Labs Inc.
02/10/2025
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Algae-C Inc. (“Algae-C”) today announced that it has been acquired by Rockcliffe Labs Inc. (“Rockcliffe Labs”), a Canadian biotechnology venture creation platform. Under the [...]
Oxford Treatment Center Brings Flexible Addiction Care to Southaven, Debuts Evening IOP with Public Meet-and-Greet
02/10/2025
SOUTHAVEN, Miss., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Oxford Treatment Center is expanding its outpatient services in Southaven with a new evening intensive outpatient program (IOP). The new evening program is designed to [...]
UPDATE — Pennant Completes Purchase of Tennessee, Georgia and Alabama Operations from UnitedHealth Group and Amedisys
02/10/2025
EAGLE, Idaho, Oct. 02, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, announced today [...]
Cross Canada VW Van Tour Will Raise Awareness For Importance Of Natural Health Products
02/10/2025
ST. ALBERT, Alberta, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Shawn Buckley can best be described as a man on a mission, with an important message to deliver. And he is delivering that message via a 1985 Volkswagen van. The [...]
Corey A. Collins Promoted to CEO of Tekton Research to Lead Next Era of Growth
02/10/2025
Growth Supports Tekton’s Strategic Focus in CNS and Cardiometabolic research AUSTIN, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Tekton Research, a leading multi-site clinical trial company, is pleased to announce the [...]
AVAVA Named Winner Best Emerging Disruptor Octane High Tech Awards
02/10/2025
Innovative Focal Point Technology™ with ComfortCool™ Delivers Regenerative Aesthetic Treatments Safe for all Skin Tones—Redefining Skin Health from the Inside Out NEWPORT BEACH, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE [...]
BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program
02/10/2025
Program has honored more than 500 members of the military since its inception Sponsorship honors both local military veterans and healthcare professionals POMPANO BEACH, Fla., Oct. 02, 2025 (GLOBE NEWSWIRE) -- BioStem [...]
A.D.A.M. Innovations Launches GeneLink, the World’s First Genetics-Powered Ad Platform
02/10/2025
TOKYO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- A.D.A.M. Innovations Co. (“A.D.A.M. Innovations”), Japan’s leading genomics and AI company, today announced the official launch of GeneLink , a breakthrough advertising platform [...]
Cirrus Therapeutics Raises $11 M Seed Financing to Advance Novel Ocular Gene Therapy to Reverse Underlying Age-Related Cause of Dry AMD
02/10/2025
Cirrus’ lead program is a novel AAV gene therapy designed to restore IRAK-M, a central regulator of the eye’s immune homeostasis, so as to prevent AMD progression and preserve central vision IRAK-M levels decrease with [...]
24/7 Market News: Kraig Labs Unlocks Spider Silk at Scale, Solving a Historical Problem for Nature’s Toughest Fiber
02/10/2025
DENVER, Oct. 02, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: [...]
Positron Corporation Enters Industry Partnership Agreement with MedAxiom
02/10/2025
Buffalo, NY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging technology company specializing in PET and PET-CT imaging systems and clinical [...]
PharmAla Completes Shipment of LaNeo™ MDMA to Johns Hopkins
02/10/2025
TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTCQB:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Cannara Announces Proposed Settlement of Convertible Debenture via Share Issuance
02/10/2025
MONTREAL, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, “the Company ”, “ us ” or “ we ”) ( TSXV: LOVE ) ( OTCQB: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
Cannara annonce le règlement proposé de débentures convertibles par le biais d’une émission d’actions
02/10/2025
MONTRÉAL, 02 oct. 2025 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») ( TSXV : LOVE ) ( OTCQB : LOVFF ) ( FRA : 8CB0) , producteur verticalement intégré de cannabis de [...]
Incendia Therapeutics Presents Two Posters on its Lead Asset PRTH-101 in Thymic Cancers at the 15th International Thymic Malignancy Interest Group (ITMIG) Annual Meeting
02/10/2025
Initial Phase 1 data suggest PRTH-101 contributes to disease control in recurrent/metastatic thymic epithelial carcinoma (TEC) with median progression-free survival (mPFS) of 7.9 months and 1 partial response (PR) [...]

Pages